A Versatile Approach to Generating Next-Generation Antibody Conjugates Through AJICAP® Technologies
Time: 9:00 am
day: Conference Day Two pt 1
Details:
• AJICAP Conjugation: Leveraging site-specific Technologies in next-generation ADCs to enhance clinically relevant biological properties through precise DAR control such as 1, 2, 4, 8 and higher
• AJICAP® Linker: Demonstrating a novel hydrophilic linker technology that enhances stability and enables versatile synthesis of ADCs with higher DAR numbers, even with highly hydrophilic payloads
• Application for new modality conjugates: Bispecific antibodies and AOCs produced by fully-chemical conjugation technology
